Filing Flows › Beam Therapeutics (BEAM) › How it makes money
How Beam Therapeutics (BEAM) makes money
Beam Therapeutics (BEAM) made $307K of revenue in the third quarter 2026 (Q3 2026), -97% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $307K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $307K | -97% |
| Q2 2026 | $490K | -94% |
| Q1 2026 | $31.7M | +325% |
| Q4 2025 | $114M | +280% |
| Q3 2025 | $9.7M | -32% |
| Q2 2025 | $8.5M | -28% |
| Q1 2025 | $7.5M | +0.8% |
From Beam Therapeutics' 10-Q filed Nov 3, 2026 (on EDGAR).
Questions
How does Beam Therapeutics make money?
Beam Therapeutics (BEAM) made $307K of revenue in the third quarter 2026 (Q3 2026), -97% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.